VUJOSEVIC, STELA
VUJOSEVIC, STELA
Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche
Patient and Physician Perspectives of Diabetic Retinopathy and Diabetic Macular Edema Diagnosis, Treatment and Progression: A Podcast Article
2025 D. Newman, B. Warren, R. Barker, C.C. Wykoff, S. Vujosevic
HD-OCT Angiography and SD-OCT in Patients with Mild or No Clinically Apparent Diabetic Retinopathy
2025 M. Vinkovic, A. Kopic, T. Benasic, D. Biuk, I. Maduna, S. Vujosevic
Clinical Trial Simulation in Diabetic Retinopathy: Insights from Patients and Site Staff
2025 S. Vujosevic, I. Gunderson, A. Burale, B. Moody, R.C. Stacy, M. Gliem
BRIDGE: a multi-stakeholder workstream focused on assessing new clinical endpoints in ophthalmology clinical trials [Building Research Innovations and Developing Global Endpoints]
2025 S. Sivaprasad, A. Loewenstein, A. Carneiro, E. Midena, F. Bandello, J.H. Terheyden, J. Korobelnik, J. Zarranz-Ventura, F. Viola, M.R. Munk, N. Eter, P. Lanzetta, R. Gale, S. Vujosevic, T. Peto, F. Faraldi, J. Cunha-Vaz, R.P. Finger, A. Joussen, D. Pauleikhoff, F.G. Revel, N. Zakaria, T. Fussaro, I. De Goeij, S. Bakalash, A. Want, D. Urban, H.N. Sen, A. Berliner, C.O. Glittenberg, A. Webler-Messenger, J.L. Pluim, M. Tolentino, D. Callanan, C. Baumal, R. Safaei, R. Hasan, M.A. Memon, M. Sylvanowicz, J. Carrasco, N. Rodellar Sasot, T.F. Miller, L. Narouz-Ott, S. Specker, F. Baschiera
New generation agents for glycemic control and diabetic retinopathy progression: what we need to know?
2025 S. Vujosevic, C. Toma, A. Ferrulli, S. De Cilla, P. Nucci, L. Luzi
Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 Oaks Trial
2025 U. Chakravarthy, R. Schwartz, R.H. Guymer, F.G. Holz, A.V. Rachitskaya, S. Vujosevic, P. Lewis, H. Vorwerk, A.Y. Alibhai, E.M. Moult, M.U. Morales, C. Bliss, C.R. Baumal, N.K. Waheed
Effect of Faricimab versus Aflibercept on Hyperreflective Foci in Patients with Diabetic Macular Edema from the YOSEMITE/RHINE Trials
2025 U. Chakravarthy, V. Chaudhary, S.R. Sadda, C.S. Tan, S. Vujosevic, S. Fauser, K. Gibson, C. Glittenberg, N. Holekamp, B. Lanza, A. Maunz, J.R. Willis, R.P. Singh
Detection of Center-Involved Diabetic Macular Edema With Visual Impairment Using Multimodal Artificial Intelligence Algorithms
2025 T. Tan, Y.P. Ng, C. Calhoun, J.Q. Chaung, J. Yao, Y. Wang, L. Zhen, X. Xu, Y. Liu, R.S.M. Goh, G. Piccoli, S. Vujosevic, G.S.W. Tan, J.K. Sun, D.S.W. Ting
Real-world evidence of anti-VEGF therapies in patients with neovascular age-related macular degeneration in Italy: The RADIANCE study
2025 M. Parravano, F. Viola, M. Nicolo, S. Vujosevic, L. Bianchino, E. Sicari, G. Villa, P. Lanzetta
One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry
2024 H. Mehta, P. Gabrielle, Y. Hashimoto, G.D. Kibret, J. Arnold, T. Guillaumie, W.J. Kheir, G. Kok, S. Vujosevic, L. O'Toole, E. Mangelschots, N. Jaross, L. Ceklic, V. Daien, F. Viola, D. Squirrell, F.J. Lavid, C. Creuzot-Garcher, D. Barthelmes, M. Gillies
Optical coherence tomography in the management of diabetic macular oedema
2024 S.K. Szeto, T.Y. Lai, S. Vujosevic, J.K. Sun, S.R. Sadda, G. Tan, S. Sivaprasad, T.Y. Wong, C.Y. Cheung
Severity of Disorganization of Retinal Layers and Visual Function Impairment in Diabetic Retinopathy
2024 S. Vujosevic, C. Alovisi, G. Piccoli, M. Brambilla, E. Torti, E. Marenzi, F. Leporati, L. Luzi, P. Nucci
Paracentral acute middle maculopathy and risk of cardiovascular disease, stroke, and death: a longitudinal study
2024 C. Limoli, L.D. Raja, S.K. Wagner, P.J. Patel, L. Nicholson, M. Bolz, S. Vujosevic, P. Nucci, P.A. Keane, H. Khalid, J. Huemer
Optical coherence tomography biomarkers indicating visual enhancement in diabetic macular edema resolved through anti-VEGF therapy: OCT biomarkers in resolved DME
2024 P. Viggiano, S. Vujosevic, F. Palumbo, M.O. Grassi, G. Boscia, E. Borrelli, M. Reibaldi, L. Sborgia, T. Molfetta, F. Evangelista, G. Alessio, F. Boscia
Multiple sclerosis
2024 S. Vujosevic
Olfactory dysfunction in patients with type 2 diabetes mellitus
2024 A. Cardella, A. Ferrulli, S. Vujosevic, A. Preti, F. Ambrogi, I. Terruzzi, A. Cecamore, A. Yakirevitch, A. Schindler, L. Luzi, F. Mozzanica
Clinical Features Related to OCT Angiography Artifacts in Patients with Diabetic Macular Edema
2024 S. Tamer Kaderli, G. Piccoli, C. Limoli, S. Ginelli, S. Caboni, L. Brotto, E. Torti, L. O'Toole, P. Nucci, S. Vujosevic
Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema
2024 J. Yao, J. Lim, G.Y.S. Lim, J.C.L. Ong, Y. Ke, T.F. Tan, T. Tan, S. Vujosevic, D.S.W. Ting
A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography
2024 S. Vujosevic, C. Limoli, G. Piccoli, E. Costanzo, E. Marenzi, E. Torti, D. Giannini, M.S. Polito, L. Luzi, P. Nucci, M. Parravano
Measuring Quality of Life in Diabetic Retinal Disease: A Narrative Review of Available Patient-Reported Outcome Measures
2024 S. Vujosevic, E. Chew, L. Labriola, S. Sivaprasad, E. Lamoureux